SCHEMBL2117407

SCHEMBL2117407

Clc1nc(-c2nc(Cc3ccccc3)co2)nc(Cl)c1Cl

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.43
DRD4 P21917 4/20 0.43
DRD3 P35462 4/20 0.43
ALDH1A1 P00352 2/20 0.39
PPARG P37231 3/20 0.37
PPARA Q07869 3/20 0.37
BRD4 O60885 6/20 0.37
RAB9A P51151 2/20 0.35
NPC1 O15118 1/20 0.35
HTT P42858 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.34
KMT2A Q03164 1/20 0.34
CTRC Q99895 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2117943 0.79 PPARG (0.40) DRD2DRD4DRD3ALDH1A1PPARG
SCHEMBL1201119 0.74 DRD2 (0.43) DRD2DRD4DRD3ALDH1A1PPARG
SCHEMBL28279483 0.71 EGFR (0.43) DRD2DRD4DRD3ALDH1A1PPARG
SCHEMBL4542844 0.71 CHUK (0.42) DRD2DRD4DRD3ALDH1A1PPARG
SCHEMBL2117744 0.70 DRD2 (0.44) DRD2DRD4DRD3ALDH1A1RAB9A
SCHEMBL29171105 0.70 CALM1 (0.42) DRD2DRD4DRD3ALDH1A1RAB9A
SCHEMBL2116108 0.69 L3MBTL1 (0.51) ALDH1A1RAB9ANPC1HTTLMNA
SCHEMBL10048357 0.69 RAB9A (0.43) ALDH1A1RAB9ANPC1HTTLMNA
SCHEMBL2262370 0.68 ENPP3 (0.44) ALDH1A1BRD4RAB9ANPC1LMNA
SCHEMBL4812206 0.68 DRD2 (0.38) DRD2DRD4DRD3PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101646657-B Process for producing trichloropyrimidine compound SUMITOMO CHEMICAL CO JP 2012-08-08 CN disclosed
US-8158787-B2 Process for producing trichloropyrimidine compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-04-17 US disclosed
US-20100160630-A1 PROCESS FOR PRODUCING TRICHLOROPYRIMIDINE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-24 US disclosed
EP-2128141-A1 PROCESS FOR PRODUCING TRICHLOROPYRIMIDINE COMPOUND Sumitomo Chemical Company, Limited (JP) 2009-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160630-A1 PROCESS FOR PRODUCING TRICHLOROPYRIMIDINE COMPOUND DPYD, TYMP, TST DRD2 1883/4885DRD4 1491/4885DRD3 2717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.